DITA META-EVO Rx

Marsoni

M251S

$700.00

Get it in 3 business days with 1 day shipping. Friday, May 29

DITA META-EVO RxMETA EVO RX war ein optisches Konzept, das aus dem Wunsch entstand, historische Stile in moderne Brillen zu integrieren. META EVO RX feiert sein Debt als erster komplett randloser Stil, der von DITA seit ber 20 Jahren herausgebracht wurde. Diese Wiedereinfhrung eines komplett randlosen optischen Stils ist eine Hommage an die Retro Stile der Vergangenheit. META EVO RX ist in der aktuellen optischen Linie wirklich einzigartig und wurde entwickelt, um

Easy Shipping

Quick Dispatch:

Your DITA META-EVO Rx orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your DITA META-EVO Rx ships.

Need Help?
Questions about DITA META-EVO Rx, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for DITA META-EVO Rx in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

I bought these shoes for my husband. He has a very hard time finding quality, comfortable shoes. These shoes are just as comfortable as his New Balance. He uses them as a dress shoe and wears them at least once a week. There was no break in period necessary. They were comfortable right out of the box! The only thing we didn't like was the white sole color. Once I knew he was going to keep them, I used a black sharpie marker to color the soles black. Instant amazing, comfortable dress shoes. They were well worth the cost. If you or your SO needs a comfortable pair of shoes, we highly recommend them.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on September 2, 2025